 |
|
FOR IMMEDIATE RELEASE iSirona Closes First Round of FundingHealthcare Technology Company Focused on Automating Patient Data CollectionPanama City, Fla. – March 17, 2008 – iSirona®, an innovative
provider of data automation solutions for healthcare providers, today announced
that the company has completed a private placement of $1 million. This funding
will enable iSirona (www.isirona.com) to invest more heavily in research
and development, expand its sales force and engage in additional marketing
efforts. Carl Witonsky and Jim Hall, two investors who each bring extensive experience in the healthcare industry, are joining the iSirona board of directors. “Based on early demand for this product, healthcare facilities are recognizing the benefits of improved accuracy and timeliness of patient data,” Witonsky explains. “This solution significantly reduces the cost and risk of making the connection between devices and clinical information systems.” Witonsky has over 35 years of healthcare operational and venture capital experience. He previously was managing director of The Flying W Fund, a satellite group of St. Paul Venture Capital, where he focused on investments in healthcare information technology. Witonsky started his career in the healthcare sector with Shared Medical Systems (now Siemens) and since has served as chairman of the board of Integrated Medical Management, interim CEO of CliniComp, CEO of MediCode and chairman of the board of Pace Health Management. Currently, Witonsky serves on the board of Dairyland Healthcare Solutions and is chairman of the board of Sentillion, Inc. Jim Hall also brings extensive healthcare information technology experience to the iSirona board. Prior to 2007, Hall was a leader in the Eclipsys organization for 10 years as COO, president and vice chairman. He also spent 10 years at Shared Medical Systems (now Siemens), where he was a member of the office of the chairman and was senior vice president of sales, marketing and product development. “Healthcare providers are realizing the increasing need to transfer patient data between devices and clinical information systems,” says Dave Dyell, iSirona president and CEO. “This funding, combined with the success of our early adopter sites, validates the true value of our robust solution in addressing this challenge.” About iSirona Panama City, Florida-based iSirona (www.isirona.com) develops clinical automation solutions for healthcare. The iSirona Enterprise™ product suite delivers medical device data from bedside and mobile devices to clinical information systems, simplifying the process of patient data collection. iSirona accelerates return-on-investment by streamlining workflow and maximizing IT investments. Uniquely positioned to deliver the most robust solution, iSirona guarantees delivery of accurate, timely and complete patient data.
For media inquiries: |
 |